Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
BACKGROUND: Malaria in pregnancy increases the risk of maternal anemia, abortion and low birth weight. Approximately 85.3 million pregnancies occur annually in areas with Plasmodium falciparum transmission. Pregnancy has been reported to alter the pharmacokinetic properties of many anti-malarial dru...
Principais autores: | Tarning, J, Kloprogge, F, Piola, P, Dhorda, M, Muwanga, S, Turyakira, E, Nuengchamnong, N, Nosten, F, Day, N, White, N, Guerin, P, Lindegardh, N |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BioMed Central
2012
|
Registros relacionados
-
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Uganda
por: Tarning Joel, et al.
Publicado em: (2012-08-01) -
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
por: Tarning, J, et al.
Publicado em: (2013) -
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
por: Kloprogge, F, et al.
Publicado em: (2013) -
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
por: Kloprogge, F, et al.
Publicado em: (2014) -
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
por: Piola, P, et al.
Publicado em: (2010)